Author - admin

Octapharma’s NUWIQ Available at BioCare


BioCare is excited to announce that Octapharma’s NUWIQ is now available. Nuwiq is the first and only recombinant FVIII produced in human cells without chemical modification. It is indicated in children and adults with Hemophilia A for on-demand treatment &...

BioCare Named as Distributor for COAGADEX® for the Treatment of Hereditary Factor X Deficiency


BioCare announced that it has been named by Bio Products Laboratory Limited (BPL) as a distributor for Coagadex (coagulation factor X, human). Product is available for shipment. Coagadex was approved by the U.S. Food and Drug Administration...

BioCare Parent Company Named One of Arizona Business Magazine’s 40 Most Admired Companies


Blood Systems, the parent company of BioCareSD, has been selected by Arizona Business Magazine and BestCompaniesAZ as one of 40 winners of the 2015 Arizona’s Most Admired Companies Awards (MAC) and is featured in the September/October...

BioCare Provides Electronic Portal Solution for Prescription Drug Pedigrees


The USDSCSA (United States Drug Supply Chain Security Act) requires product and transaction information  for all sales of prescription drug products sold by a distributor or manufacturer effective July 1,  2015. Manufacturers and distributors are required to provide the...

Baxter Selects BioCare as Exclusive Distributor for OBIZUR


BioCare has been selected by Baxter as the exclusive, national authorized distributor for OBIZUR, the only recombinant porcine sequence factor VIII replacement treatment for acquired hemophilia A (AHA). OBIZUR was approved by the FDA for the...